Efficacy and reliability of Huperzine A in mild and moderate Alzheimer's disease

Chinese Journal of Clinical Rehabilitation

Volumn 7, Issue 31, 2003, Pages 4258-4259

  Yang, Chu Yu ^a   Lü, Ze Ping ^a   Zheng, Chen Guang ^a  

^a Guangxi Zhuangzu Zizhiqu Jiangbin Yiyuan   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUPERZINE A; PLACEBO;

ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SCORING SYSTEM; SELF CARE; SIDE EFFECT; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 2442583539     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Perry EK. Intralaminar neurochemical distributions in human cortex: comparison between AD and normal. J Neurochem 1984; 42: 1402-10
2. Jia JP, Jia JM, Zhou WD, et al. The detection of cerebrospinal fluid acetylecholine and choline in patient with Alzheimer's isease and vasilementia and their clinical significance. Zhonghua Shenjingke Zazhi 2002; 35(3): 168-70
3. Davis KL, Pollak WK, Pitney WP, et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999; 281: 1401-6
4. Xu XH. Neuroimmunology. Wuhan: Hubei Scieace & Techniqne pnblishment 2000: 327-33
5. Sun QQ, Xu SS, Pan JL, et al. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Zhongguo Yaoli Xuebao 1999; 20(7): 601-3
6. Song ZY, Lu H. A study of Huperzine A in patients with Alzheimer disease. Zhongguo Linchuang Kangfu 2003; 7(1); 112
7. Zhang ZX, Wang XD, Chen QT, et al. Clinical efficacy and safety of huperzine A in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yixue Zazhi 2002; 82(14): 941-2
8. Wang ZW, Zhang HX, Ren P. A study of Huperzine A inpatients with Alzheimer disease. Yixue Xinxi 2000; 13(8): 462-3
9. Peng DT, Xu XH, Hou QY, et al. The safety and efficacy of aricept in patients with Alzheimer disease. Zhonghua Shenjingke Zazhi 2002; 35(1): 19-21
10. Wang RQ, Lei QY, Gu JQ, et al. Nilestriol combined with huperzine in improving cognition of female patients with Alzheimer's disease. Zhongguo Linchuang Kangfu 2003; 7(10): 1538-9